Search for: "In Re: Pfizer Securities Litigation"
Results 61 - 80
of 105
Sort by Relevance
|
Sort by Date
11 Feb 2011, 7:51 am
He is available for general litigation support, medical and marketing record review, and expert witness services including depositions, expert reports and trial testimony.Areas in which Dr. [read post]
2 Oct 2010, 8:43 am
He is available for general litigation support, medical and marketing record review, and expert witness services including depositions, expert reports and trial testimony.Areas in which Dr. [read post]
30 Sep 2010, 5:58 am
Skeptics have wondered whether litigants might be able to game any substitution. [read post]
12 Aug 2010, 3:50 pm
The Chancellor explained further that: “Third, a plaintiff must also prove that information it seeks is necessary and essential to assessing whether a director is unsuitable to stand for re-election. [read post]
23 Feb 2010, 6:16 am
Of particular note, in December, the Securities and Exchange Commission (”SEC”) adopted new proxy disclosure rules that likely will be a focal point for public company directors, as the new rules relate to disclosures regarding the composition and operation of boards of directors. [1] This memorandum is an update of our client alert covering considerations for public company directors in the current environment issued on October 15, 2009. 1. [read post]
25 Jan 2010, 5:00 am
Pfizer, Inc., 2010 WL 163583, slip op. [read post]
7 Dec 2009, 6:15 am
See In re Pfizer Inc. [read post]
7 Dec 2009, 6:15 am
See In re Pfizer Inc. [read post]
3 Sep 2009, 1:24 am
"
Visit Legal Technology
Tap Your Creativity if You're Considering a Second Career Beyond Law& [read post]
2 Sep 2009, 11:22 pm
July 25, 2008) (Texas statute); In re Aredia & Zometa Products Liability Litigation, 2008 WL 913087, at *2 (M.D. [read post]
25 Jun 2009, 4:29 am
Feb. 19, 2009); In re Nuvelo, Inc., Securities Litigation, 2008 WL 5114325, at *2 (N.D. [read post]
3 Apr 2009, 5:10 am
"We're looking at better ways of aligning our interests," he said. [read post]
1 Mar 2009, 9:00 pm
In a nutshell, plaintiffs pleaded that Pfizer, "working in partnership with the Nigerian government, failed to secure the informed consent" of children (or their guardians) who were enrolled in an allegedly dangerous clinical trial of the drug Trovan. [read post]
23 Feb 2009, 5:04 am
The plaintiffs claim that Pfizer, working in partnership with the Nigerian government, failed to secure the informed consent of either the children or their guardians and specifically failed to disclose or explain the experimental nature of the study or the serious risks involved. [read post]
19 Feb 2009, 12:55 am
However, by opinion dated January 30, 2009, the United States Court of Appeals for the Third Circuit, relying on a recent decision in In re Merck & Co., Securities Derivative, & ‘ERISA’ Litigation, 543 F. 3d 150 (3d Cir. 2008), reversed the District Court. [read post]
15 Feb 2009, 2:38 am
All loans are guaranteed by the Department of Homeland Security (another component of the legislation described above). [read post]
5 Sep 2008, 11:01 pm
: (Excess Copyright), (Michael Geist), Opinion and analysis of C-61: (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), 61 reforms to C-61: (Day 50: Education harms – lessons contain limited definition of students – Michael Geist), (Day 51: Education internet exception is unnecessary – Michael Geist), (Day 52: Education internet exception is harmful – Michael Geist), (Day 53: Education internet exception… [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert Jacobsen v… [read post]
17 Jul 2008, 3:15 pm
We're just asking . . .:)By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
